11-Keto-beta-boswellic acid

Description: 11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor, it exerts dose dependent cardioprotective effect manifested by dose-dependent reduction in serum lactate dehydrogenase. Target: Lipoxygenase, Leukotriene Receptor, NF-kappaB. Smiles: [H][C@@]12[C@@H](C)[C@H](C)CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@@H](O)[C@](C)(C(O)=O)[C@]3([H])CC[C@@]12C. References: Biotransformation of 11-keto-beta-boswellic acid by Cunninghamella blakesleana.Phytochemistry. 2013 Dec,96:330-6.